U.S. Markets close in 5 hrs 22 mins
  • S&P 500

    4,395.64
    +41.45 (+0.95%)
     
  • Dow 30

    34,258.32
    +338.48 (+1.00%)
     
  • Nasdaq

    14,896.85
    +150.45 (+1.02%)
     
  • Russell 2000

    2,218.56
    +32.38 (+1.48%)
     
  • Gold

    1,768.40
    -9.80 (-0.55%)
     
  • Silver

    23.03
    +0.46 (+2.05%)
     
  • EUR/USD

    1.1696
    -0.0034 (-0.2924%)
     
  • 10-Yr Bond

    1.3360
    +0.0120 (+0.91%)
     
  • Vix

    20.87
    -3.49 (-14.33%)
     
  • GBP/USD

    1.3619
    -0.0045 (-0.3282%)
     
  • USD/JPY

    109.7800
    +0.5600 (+0.5127%)
     
  • BTC-USD

    41,507.74
    -2,366.11 (-5.39%)
     
  • CMC Crypto 200

    1,089.55
    +49.07 (+4.72%)
     
  • FTSE 100

    7,083.37
    +102.39 (+1.47%)
     
  • Nikkei 225

    29,639.40
    -200.31 (-0.67%)
     

Outlook on the Legal Cannabis Market in North America to 2026 - by Product Derived, Distribution Channel and Region

·6 min read

Dublin, Sept. 14, 2021 (GLOBE NEWSWIRE) -- The "North America Legal Cannabis Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

The North America legal cannabis market reached a value of US$ 16 Billion in 2020. Cannabis is a drug derived from the dried leaves and flowers of the hemp plant that grows in the tropical and temperate areas of the world. Also known as hash, weed, marijuana, pot, dope, smoke and cone, cannabis can be obtained in various forms ranging from the simple process of drying and curing marijuana flowers to the sophisticated chemistry of producing cannabis concentrates. In North America, the legal landscape is giving way to the decriminalization and full legalization of cannabis, owing to which it is gaining prominence for both medical and recreational purposes.

In the United States, marijuana has been legalized in 30 states for medicinal use and in 9 states for both therapeutic as well as recreational purposes. In Canada, medicinal usage of the drug has been legalized since 2001; however, its recreational use has been authorized through a bill passed in June 2018. This modification in the regulatory landscape has led to an increase in the usage of medical cannabis for treating several diseases associated with changing lifestyles such as chronic pain, depression, post-traumatic stress disorder, social anxiety, cancer, multiple sclerosis and epilepsy. Also, with the implementation of these stringent regulations, suppliers have to comply with proper safety control measures and provide consumers with high-quality products, which further acts in favor of the growth of the market.

The use of industrial hemp, a product derived from cannabis, has also expanded to a great variety of products, including health foods, organic body care, clothing, construction materials, biofuels and plastic composites. Moreover, increasing research and development (R&D) activities in the medical applications of cannabis are expected to create positive opportunities for both the existing players and new entrants in the upcoming years. Looking forward, the publisher expects the North America legal cannabis market to exhibit strong growth during the next five years.

Break up by Product Derived:

  • Marijuana

  • Industrial Hemp

Marijuana currently represents the leading segment. It is a greenish-grey mixture of the dried flowers of Cannabis sativa. The applications of marijuana are further divided on the basis of medical and recreational uses. Its therapeutic applications include the treatment of various diseases such as migraine, cancer, arthritis and others.

Break up by Distribution Channel:

  • Regulated Dispensary

  • Recreational Stores

  • Stand-Alone Retailers

  • Others

Among these, legal cannabis is mostly distributed through regulatory dispensaries.

Regional Insights:

  • United States

  • Canada

Country-wise, the United States enjoys a leading position in the market as the medical use of cannabis has been legalized in 31 states including the territories of Puerto Rico and Guam, and the District of Columbia and in 9 states including California, Nevada, Alaska and Colorado for both medicinal and recreational uses.

Competitive Landscape:

The market is highly fragmented with the presence of numerous small and large manufacturers who compete in terms of prices and quality. Some of the leading players operating in the market are:

  • 22nd Century Group, Inc

  • Medical Marijuana Inc

  • Hemp, Inc.

  • Axim Biotechnologies, Inc

  • Arena Pharmaceuticals, Inc.

  • Canopy Growth Corporation

  • Aphria Inc.

  • Aurora Cannabis Inc.

  • Abcann Medicinals Inc.

Key Questions Answered in This Report:

  • How has the North America legal cannabis market performed so far and how will it perform in the coming years?

  • What are the major countries in the North America legal cannabis market?

  • What has been the impact of COVID-19 on the North America legal cannabis market?

  • Which are the popular cannabis products in the North America legal cannabis market?

  • What are the several application segments in the North America legal cannabis market?

  • What are the primary distribution channels in the North America legal cannabis market?

  • What are the various stages in the value chain of the North America legal cannabis market?

  • What are the key driving factors and challenges in the North America legal cannabis market?

  • What is the structure of the North America legal cannabis market and who are the key players?

  • What is the degree of competition in the North America legal cannabis market?

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 North America Legal Cannabis Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Products Derived
5.5 Market Breakup by Application
5.6 Market Breakup by Country
5.7 Market Breakup by Distribution Channel
5.8 Market Forecast
5.9 SWOT Analysis
5.9.1 Overview
5.9.2 Strengths
5.9.3 Weaknesses
5.9.4 Opportunities
5.9.5 Threats
5.10 Value Chain Analysis
5.10.1 Overview
5.10.2 Research and Development
5.10.3 Raw Material Procurement
5.10.4 Manufacturing
5.10.5 Marketing
5.10.6 Distribution
5.10.7 End-Use
5.11 Porters Five Forces Analysis
5.11.1 Overview
5.11.2 Bargaining Power of Buyers
5.11.3 Bargaining Power of Suppliers
5.11.4 Degree of Competition
5.11.5 Threat of New Entrants
5.11.6 Threat of Substitutes
5.12 Key Success and Risk Factors in the North American Cannabis Market

6 Performance of Key Regions
6.1 United States
6.1.1 Market Overview
6.1.2 Market Performance
6.1.3 Market Breakup by Products Derived
6.1.4 Market Breakup by Application
6.1.5 Market Breakup by States
6.1.6 Market Breakup by Distribution Channel
6.1.7 Market Forecast
6.1.8 Legal & Regulatory Framework
6.2 Canada
6.2.1 Market Overview
6.2.2 Market Performance
6.2.3 Market Breakup by Products Derived
6.2.4 Market Breakup by Application
6.2.5 Market Breakup by Distribution Channel
6.2.6 Market Forecast
6.2.7 Legal & Regulatory Framework

7 Market by Products Derived
7.1 Marijuana
7.1.1 Market Performance
7.1.2 Market Breakup by Application
7.1.2.1 Medical
7.1.2.1.1 Migraine
7.1.2.1.2 Arthritis
7.1.2.1.3 Cancer
7.1.2.1.4 Others
7.1.2.2 Recreational Use
7.2 Industrial Hemp
7.2.1 Market Performance
7.2.2 Market Breakup by Application
7.2.2.1 Personal Care
7.2.2.2 Hemp CBD
7.2.2.3 Food
7.2.2.4 Consumer Textile
7.2.2.5 Others
7.3 Others

8 Market Breakup by Distribution Channel
8.1 Regulated Dispensary
8.2 Recreational Stores
8.3 Stand-Alone Retailer
8.4 Others

9 Competitive Landscape
9.1 Market Structure
9.2 Key Players
9.3 Profiles of Key Players

For more information about this report visit https://www.researchandmarkets.com/r/aelwi3

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900